Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Drugs|September 28, 2011
Clinically significant drug interactions with antacids: an updateRyuichi Ogawa, Hirotoshi Echizen
Clinical Pharmacokinetics|July 9, 2010
Drug-drug interaction profiles of proton pump inhibitorsRyuichi Ogawa, Hirotoshi Echizen
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 18, 2014
Simultaneous determination of N(1)-methylnicotinamide, L-carnitine, and creatinine in human plasma and urine by liquid chromatography with mass spectrometry for assessing the activities of multiple renal cationic transportersYuji Nobuoka, Ryuichi Ogawa, Hirotoshi Echizen
Clinical Pharmacokinetics|September 25, 2014
Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 2, drugs administered orally)Ryuichi Ogawa, Joan M Stachnik, Hirotoshi Echizen
Clinical Pharmacokinetics|January 25, 2013
Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 1, drugs administered intravenously)Ryuichi Ogawa, Joan M Stachnik, Hirotoshi Echizen
European Journal of Drug Metabolism and Pharmacokinetics|July 21, 2018
Reduced Clearance of Phenobarbital in Advanced Cancer Patients near the End of LifeHirokazu Nakayama, Hirotoshi Echizen, Ryuichi Ogawa, et al.
International Journal of Clinical Pharmacology and Therapeutics|March 6, 2013
Population pharmacokinetic and pharmacodynamic analyses of teicoplanin in Japanese patients with systemic MRSA infectionRyuichi Ogawa, Seiichi Kobayashi, Yuki Sasaki, et al.
Journal of Pharmaceutical Health Care and Sciences|January 25, 2017
Impact of Pharmacists' audit on improving the quality of prescription of dabigatran etexilate methanesulfonate: a retrospective studyTeppei Shimizu, Yoshio Momose, Ryuichi Ogawa, et al.
Biological & Pharmaceutical Bulletin|February 3, 2016
Eculizumab Dosing Intervals Longer than 17 Days May Be Associated with Greater Risk of Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal HemoglobinuriaHirokazu Nakayama, Kensuke Usuki, Hirotoshi Echizen, et al.
Therapeutic Drug Monitoring|March 23, 2017
Induration at Injection or Infusion Site May Reduce Bioavailability of Parenteral Phenobarbital AdministrationHirokazu Nakayama, Hirotoshi Echizen, Ryuichi Ogawa, et al.
Pageof 7